Skip to main content
Top
Published in: Journal of Cancer Research and Clinical Oncology 5/2016

01-05-2016 | Original Article – Clinical Oncology

Tumor characteristics and therapy of elderly patients with breast cancer

Authors: A.-M. Grumpelt, A. Ignatov, S. N. Tchaikovski, E. Burger, S.-D. Costa, H. Eggemann

Published in: Journal of Cancer Research and Clinical Oncology | Issue 5/2016

Login to get access

Abstract

Introduction

Elderly breast cancer patients aged ≥75 years are underrepresented in most studies. Therefore, data on cancer characteristics, adjuvant treatment and survival in elderly patients are missing.

Patients and methods

In this retrospective study, we compared tumor characteristics and adjuvant therapy in 973 women with invasive, non-metastasized breast cancer aged ≥75 years with 3377 younger postmenopausal patients (50–74 years old). Time dynamics of tumor characteristics were investigated, comparing two observation periods between the years 2000–2004 versus 2005–2008.

Results

Compared to younger women, older patients were more often treated with mastectomy and less likely to receive adjuvant treatment. Although the overall survival rate increased over the observation period in both age groups, the older study group was characterized by shorter disease-free survival. Additionally, we observed an increase in about 1.65 years in the age at diagnosis as well as an increasing rate of breast-conserving surgery and sentinel lymph node biopsy for the whole study population between 2000 and 2008. Furthermore, we found a reduction in the proportion of estrogen receptor-positive tumors in the younger women and a decrease in G3-tumors in both age groups over the study time.

Conclusion

The older group’s reduced disease-free survival could be explained by the tumor characteristics and differences in the adjuvant treatment. Remarkably, elderly women are more likely to be overtreated surgically while being undertreated in terms of adjuvant therapy.
Literature
go back to reference AGO (2013) Aktuelle Empfehlungen zur Prävention, Diagnostik und Therapie früher und fortgeschrittener Mammakarzinome: State of the Art 2013, 6th edn. Forschen, lehren, heilen, Zuckschwerdt, München AGO (2013) Aktuelle Empfehlungen zur Prävention, Diagnostik und Therapie früher und fortgeschrittener Mammakarzinome: State of the Art 2013, 6th edn. Forschen, lehren, heilen, Zuckschwerdt, München
go back to reference Chavez-MacGregor M, Zhang N, Buchholz TA et al (2013) Trastuzumab-related cardiotoxicity among older patients with breast cancer. J Clin Oncol 31(33):4222–4228CrossRefPubMedPubMedCentral Chavez-MacGregor M, Zhang N, Buchholz TA et al (2013) Trastuzumab-related cardiotoxicity among older patients with breast cancer. J Clin Oncol 31(33):4222–4228CrossRefPubMedPubMedCentral
go back to reference Cuzick J, Sestak I, Baum M, Buzdar A, Howell A, Dowsett M, Forbes JF (2010) Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial. Lancet Oncol 11:1135–1141CrossRefPubMed Cuzick J, Sestak I, Baum M, Buzdar A, Howell A, Dowsett M, Forbes JF (2010) Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial. Lancet Oncol 11:1135–1141CrossRefPubMed
go back to reference Ewijk RJG, Schwentner L, Wöckel A et al (2013) Trends in patient characteristics, treatment and survival in breast cancer in a non-selected retrospective clinical cohort study of 2,600 patients. Arch Gynecol Obstet 287(1):103–110CrossRefPubMed Ewijk RJG, Schwentner L, Wöckel A et al (2013) Trends in patient characteristics, treatment and survival in breast cancer in a non-selected retrospective clinical cohort study of 2,600 patients. Arch Gynecol Obstet 287(1):103–110CrossRefPubMed
go back to reference Garreau JR, Delamelena T, Walts D, Karamlou K, Johnson N (2006) Side effects of aromatase inhibitors versus tamoxifen: the patients’ perspective. Am J Surg 192:496–498CrossRefPubMed Garreau JR, Delamelena T, Walts D, Karamlou K, Johnson N (2006) Side effects of aromatase inhibitors versus tamoxifen: the patients’ perspective. Am J Surg 192:496–498CrossRefPubMed
go back to reference Gennari R, Curigliano G, Rotmensz N et al (2004) Breast carcinoma in elderly women: features of disease presentation, choice of local and systemic treatments compared with younger postmenopausal patients. Cancer 101(6):1302–1310CrossRefPubMed Gennari R, Curigliano G, Rotmensz N et al (2004) Breast carcinoma in elderly women: features of disease presentation, choice of local and systemic treatments compared with younger postmenopausal patients. Cancer 101(6):1302–1310CrossRefPubMed
go back to reference Hamaker ME, Bastiaannet E, Evers D et al (2013) Omission of surgery in elderly patients with early stage breast cancer. Eur J Cancer 49(3):545–552CrossRefPubMed Hamaker ME, Bastiaannet E, Evers D et al (2013) Omission of surgery in elderly patients with early stage breast cancer. Eur J Cancer 49(3):545–552CrossRefPubMed
go back to reference Honma N, Sakamoto G, Akiyama F et al (2003) Breast carcinoma in women over the age of 85: distinct histological pattern and androgen, oestrogen, and progesterone receptor status. Histopathology 42(2):120–127CrossRefPubMed Honma N, Sakamoto G, Akiyama F et al (2003) Breast carcinoma in women over the age of 85: distinct histological pattern and androgen, oestrogen, and progesterone receptor status. Histopathology 42(2):120–127CrossRefPubMed
go back to reference Hughes KS, Schnaper LA, Bellon JR et al (2013) Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343. J Clin Oncol 31(19):2382–2387CrossRefPubMedPubMedCentral Hughes KS, Schnaper LA, Bellon JR et al (2013) Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343. J Clin Oncol 31(19):2382–2387CrossRefPubMedPubMedCentral
go back to reference Hutchins LF, Unger JM, Crowley JJ et al (1999) Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med 341(27):2061–2067CrossRefPubMed Hutchins LF, Unger JM, Crowley JJ et al (1999) Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med 341(27):2061–2067CrossRefPubMed
go back to reference Mustacchi G, Cazzaniga ME, Pronzato P et al (2007) Breast cancer in elderly women: a different reality? results from the NORA study. Ann Oncol 18(6):991–996CrossRefPubMed Mustacchi G, Cazzaniga ME, Pronzato P et al (2007) Breast cancer in elderly women: a different reality? results from the NORA study. Ann Oncol 18(6):991–996CrossRefPubMed
go back to reference Pappo I, Karni T, Sandbank J et al (2007) Breast cancer in the elderly: histological, hormonal and surgical characteristics. Breast 16(1):60–67CrossRefPubMed Pappo I, Karni T, Sandbank J et al (2007) Breast cancer in the elderly: histological, hormonal and surgical characteristics. Breast 16(1):60–67CrossRefPubMed
go back to reference Rosenberg J, Chia YL, Plevritis S (2005) The effect of age, race, tumor size, tumor grade, and disease stage on invasive ductal breast cancer survival in the U.S. SEER database. Breast Cancer Res Treat 89(1):47–54CrossRefPubMed Rosenberg J, Chia YL, Plevritis S (2005) The effect of age, race, tumor size, tumor grade, and disease stage on invasive ductal breast cancer survival in the U.S. SEER database. Breast Cancer Res Treat 89(1):47–54CrossRefPubMed
go back to reference Rudenstam C, Zahrieh D, Forbes JF et al (2006) Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group Trial 10-93. J Clin Oncol 24(3):337–344CrossRefPubMed Rudenstam C, Zahrieh D, Forbes JF et al (2006) Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group Trial 10-93. J Clin Oncol 24(3):337–344CrossRefPubMed
go back to reference Schonberg MA, Marcantonio ER, Li D et al (2010) Breast cancer among the oldest old: tumor characteristics, treatment choices, and survival. J Clin Oncol 28(12):2038–2045CrossRefPubMedPubMedCentral Schonberg MA, Marcantonio ER, Li D et al (2010) Breast cancer among the oldest old: tumor characteristics, treatment choices, and survival. J Clin Oncol 28(12):2038–2045CrossRefPubMedPubMedCentral
go back to reference Schoppmann SF, Bayer G, Aumayr K et al (2004) Prognostic value of lymphangiogenesis and lymphovascular invasion in invasive breast cancer. Ann Surg 240(2):306–312CrossRefPubMedPubMedCentral Schoppmann SF, Bayer G, Aumayr K et al (2004) Prognostic value of lymphangiogenesis and lymphovascular invasion in invasive breast cancer. Ann Surg 240(2):306–312CrossRefPubMedPubMedCentral
go back to reference Schrodi S, Braisch U, Schenkirsch G et al (2013) Veränderungen der Therapie des Mammakarzinoms in Bayern seit Einführung des Mammografie-Screenings. Eine Analyse bayerischer Krebsregisterdaten der Jahre 2000 bis 2008. Gesundheitswesen Schrodi S, Braisch U, Schenkirsch G et al (2013) Veränderungen der Therapie des Mammakarzinoms in Bayern seit Einführung des Mammografie-Screenings. Eine Analyse bayerischer Krebsregisterdaten der Jahre 2000 bis 2008. Gesundheitswesen
go back to reference Wang J, Kollias J, Boult M et al (2010) Patterns of surgical treatment for women with breast cancer in relation to age. Breast J 16(1):60–65CrossRefPubMed Wang J, Kollias J, Boult M et al (2010) Patterns of surgical treatment for women with breast cancer in relation to age. Breast J 16(1):60–65CrossRefPubMed
Metadata
Title
Tumor characteristics and therapy of elderly patients with breast cancer
Authors
A.-M. Grumpelt
A. Ignatov
S. N. Tchaikovski
E. Burger
S.-D. Costa
H. Eggemann
Publication date
01-05-2016
Publisher
Springer Berlin Heidelberg
Published in
Journal of Cancer Research and Clinical Oncology / Issue 5/2016
Print ISSN: 0171-5216
Electronic ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-015-2111-2

Other articles of this Issue 5/2016

Journal of Cancer Research and Clinical Oncology 5/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.